QuidelOrtho Corporation (QDEL) Stock Analysis

Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players

Wed, September 16, 2026 at 9:05 AM UTC 2 min read

The Point of Care Diagnostics market is projected to grow from $20.63 billion in 2026 to $31.46 billion by 2031, highlighting significant expansion opportunities in the sector. QuidelOrtho, a key player in this market, stands to benefit from this growth, potentially enhancing its revenue and market share. Investors should consider this trend as it indicates a favorable environment for companies involved in innovative diagnostic solutions, including QuidelOrtho.

Read full article →

QuidelOrtho (QDEL) Is Up 6.0% After Cutting 2026 Revenue Outlook Amid Narrowing Losses – What's Changed

Tue, August 18, 2026 at 2:09 AM UTC 2 min read

QuidelOrtho (QDEL) shares rose 6.0% following the company's decision to lower its revenue outlook for 2026, despite reporting narrowing losses. This adjustment reflects ongoing challenges in the market but may signal a more focused strategy to enhance profitability. Investors should consider the implications of the revised forecast on future growth and the company's ability to manage costs effectively.

Read full article →